16-dehydropregnenolone has been researched along with Benign Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bratoeff, E; Cabeza, M; Heuze, Y; Ramírez-Apan, T; Sánchez, A; Silva-Ortiz, AV; Soriano, J | 1 |
1 other study(ies) available for 16-dehydropregnenolone and Benign Neoplasms
Article | Year |
---|---|
Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cholestenone 5 alpha-Reductase; Humans; Male; Mesocricetus; Neoplasms; Pregnenolone; Rats | 2015 |